Topics

The mechanism of action of an antitumour drug used for the treatment of gliobla

20:00 EDT 1 May 2019 | AAAS

(Institute for Research in Biomedicine (IRB Barcelona)) The antibody mAb806 is used to treat glioblastoma, although its mechanism of action has been unknown until now. The study, published in the journal PNAS, paves the way to extend treatment with mAb806 to more types of tumours and to the development of more personalised therapies.

Original Article: The mechanism of action of an antitumour drug used for the treatment of gliobla

NEXT ARTICLE

More From BioPortfolio on "The mechanism of action of an antitumour drug used for the treatment of gliobla"

Quick Search

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...